Long Covid Impact on Adult Americans: Early Indicators Estimating Prevalence and Cost [open pdf - 0B]
From the Executive Summary: "While most patients recover from COVID-19 [coronavirus disease 2019], as many as half experience lingering symptoms six or more months after their initial infection.1 Long Covid is the patient-preferred term used to describe this experience of post-infection illness. Long Covid includes a broad range of symptoms that can be disabling, prevent the patient's recovery to pre-infection health, and thwart the patient's return to the workforce. Using mathematical models, publicly available data, patient-led research, and the published natural histories of other post-infection illnesses, specifically myalgic encephalomyelitis/chronic fatigue syndrome (ME/ CFS), Solve M.E. estimates the prevalence and cost of Long Covid on adult Americans, presented here. Most importantly, these estimates differentiate between persons with milder symptoms and those experiencing disability or inability to work. While noting limitations of population and serology data, including under-reporting and gender bias, these mathematical models and analyses were developed with a specific emphasis on the impacts of this mass disabling event on American labor markets and labor shortages."
Solve ME/CFS Initiative
Solve ME/CFS Initiative: https://solvecfs.org/